TickerHumHealthcare · covered US companies
Drug Manufacturers—General stocks, compared by the numbers
Explore valuation, revenue growth, operating margins and research scores side by side. Each metric is ranked separately—this is context, not a “best stock” list.
9 of 9 covered companies loaded.
| Company | Price | P/E ↓ | Revenue growth ↑ | Operating margin ↑ | Research score ↑ |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $266.28 | #7 75.2x | #2 10.4% | #2 26.2% | #6 56/100 |
| Biogen Inc. (BIIB) | $228.69 | #2 24.6x | #8 1.2% | — | #5 64/100 |
| Amgen Inc. (AMGN) | $418.13 | #3 26.0x | #3 9.1% | #1 30.0% | #3 67/100 |
| Gilead Sciences, Inc. (GILD) | $152.21 | — | #5 5.5% | #3 -8.2% | #9 42/100 |
| Johnson & Johnson (JNJ) | $271.95 | #4 31.5x | #4 8.1% | — | #4 65/100 |
| Bristol-Myers Squibb Company (BMY) | $63.88 | #1 14.1x | #7 3.1% | — | #1 71/100 |
| Eli Lilly and Company (LLY) | $1,184.78 | #6 39.8x | #1 49.6% | — | #2 69/100 |
| Merck & Co., Inc. (MRK) | $148.69 | #8 119.0x | #6 4.6% | — | #7 51/100 |
| Pfizer Inc. (PFE) | $28.72 | #5 37.8x | #9 -0.2% | — | #7 51/100 |
Ranks compare only covered companies in this catalogue industry. Lower positive P/E ranks better; higher revenue growth, operating margin and research score rank better. Ties share a rank and missing values are excluded.